p53 in Relation to Therapeutic Outcome of Locoregional Chemotherapy in Pancreatic Cancer

1999 ◽  
Vol 880 (1 CELL AND MOLE) ◽  
pp. 281-287 ◽  
Author(s):  
FRANK GANSAUGE ◽  
SUSANNE GANSAUGE ◽  
KARL H. LINK ◽  
HANS G. BEGER
2016 ◽  
Vol 27 (8) ◽  
pp. 1546-1556 ◽  
Author(s):  
S. Jagadeeshan ◽  
A. Subramanian ◽  
S. Tentu ◽  
S. Beesetti ◽  
M. Singhal ◽  
...  

Pancreas ◽  
2002 ◽  
Vol 25 (4) ◽  
pp. 366-372 ◽  
Author(s):  
Hiroki Yamaue ◽  
Masaji Tani ◽  
Hironobu Onishi ◽  
Hiroyuki Kinoshita ◽  
Mikihito Nakamori ◽  
...  

Pancreas ◽  
2011 ◽  
Vol 40 (4) ◽  
pp. 600-607 ◽  
Author(s):  
Yuki Fujiwara ◽  
Kenei Furukawa ◽  
Yohta Shimada ◽  
Tomonori Iida ◽  
Hiroaki Shiba ◽  
...  

2019 ◽  
Vol 18 ◽  
pp. 112-121 ◽  
Author(s):  
Vijay S. Madamsetty ◽  
Anil Sharma ◽  
Maria Toma ◽  
Stefanie Samaniego ◽  
Audrey Gallud ◽  
...  

Author(s):  
A. V. Kozlov ◽  
P. G. Tarazov

The review presents an analysis of the literature and our own data on the use of intra-arterial chemotherapy in pancreatic cancer. It is concluded that transcatheter arterial administration of cytostatics is a relatively safe and effective method of treatment. Combination of celiac axis infusion with arterial chemoembolization, as well as infusion with radiotherapy increase the survival. Neoand adjuvant arterial chemotherapy improves the results of pancreatic surgery. The use of new locoregional chemotherapy regimens is promising and requires further study.


2001 ◽  
Vol 120 (5) ◽  
pp. A162-A162
Author(s):  
A KUTUP ◽  
S HOSCH ◽  
S PAPE ◽  
P SCHEUNEMANN ◽  
W KNOEFEL ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document